DYADIC INTERNATIONAL INC DYAI 深 滬
等待開盤 11-01 09:30:00 美东时间
1.145
-0.025
-2.14%
華盛通- 最 高1.20
- 今 開1.20
- 成交量 5.36万股
- 最 低 1.10
- 昨 收 1.17
- 總市值 3445.39万
- 52周最高 2.20
- 市盈率 靜 --
- 換手率 0.18%
- 52周最低 0.711
- 委 比 87.50%
- 總股本 3009.07万
- 歷史最高 10.98
- 量 比 0.63
- 振 幅 8.55%
- 歷史最低 0.711
- 每 手 1
- 風險率 0.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 上调目标价！特斯拉、赛默飞世尔、拉姆研究、波士顿科学、安诺电子、金沙集团等获众多机构评级
今日重点评级关注：摩根士丹利：维持Viking Therapeutics"超配"评级，目标价从98美元升至102美元；摩根大通：维持IDEAYA Biosciences"超配"评级，目标价从74美元升至79美元
10-24 09:51
HC Wainwright & Co. Assumes Dyadic International at Buy, Announces Price Target of $3
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Dyadic International (NASDAQ:DYAI) with a Buy rating and announces Price Target of $3.
10-23 18:41
Dyadic International Achieves Milestone Payments and Compliance
The latest update is out from Dyadic International ( ($DYAI) ). On October 6, 2...
10-08 04:55
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
Dyadic Applied BioSolutions reported Q3 2025 milestones, including $500,000 for Proliant partnership and $250,000 from Inzymes collaboration. Key advancements in recombinant proteins for life sciences and food nutrition include commercial launches targeted for late 2025 and early 2026, along with expanded sampling and production activities. The company is transitioning to a commercially focused strategy, capitalizing on its diverse product pipeli...
10-06 12:30
Sidoti Events, LLC's Virtual September Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an af...
09-16 23:20
Dyadic to Present at Investor Conferences and BPI East
Dyadic International, Inc., a global biotechnology company, announced that its President & COO, Joe Hazelton, will present at three upcoming conferences: H.C. Wainwright Global Investment Conference (September 8-10, 2025), BioProcess International BPI East (September 15-18, 2025), and Sidoti Small Cap Investor Event (September 17-18, 2025). Dyadic focuses on producing high-value proteins for non-therapeutic applications using its proprietary plat...
09-04 13:00
Dyadic国际预计将实现50万美元里程碑收入
生物技术平台Dyadic国际（Dyadic International，DYAI）下跌2.3%。该公司宣布在向商业化生物技术企业转型过程中，预计将实现50万...
08-14 23:16
Dyadic International shares are trading higher after the company reported a Q2 sales beat.
Dyadic International shares are trading higher after the company reported a Q2 ...
08-14 20:40
Dyadic anticipates $500,000 milestone and targets commercialization ramp through 2026
Earnings Call Insights: Dyadic International, Inc. (DYAI) Q2 2025 Management View Joseph P. Hazelton, President & COO, stated Dyadic has shifted from a platform-focused R&D company to a commercially-d...
08-14 07:52
CORRECTION: Dyadic International Q2 EPS $(0.06), Inline, Sales $966.630K Beat $600.000K Estimate
Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last
08-14 05:40
